Graf Akcie ABUS (Arbutus Biopharma Corp). Diskuze k akciím ABUS. Aktuální informace ABUS.

Základní informace o společnosti Arbutus Biopharma Corp (Akcie ABUS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	396.34M
Hodnota podniku (EV)	354.96M
Tržby	8.351M
EBITDA	-65.46
Zisk	-84.19
Růst v tržbách Q/Q	53.83 %
Růst v tržbách Y/Y	8.68 %
P/E (Cena vůči ziskům)	N/A
Forward P/E	-19.68
EV/Sales	42.50
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	47.46
P/FCF	N/A
Price/Book	3.89
Účetní hodnota na akcii	1.04
Hotovost na akcii	1.26
FCF vůči ceně	-15.13 %
Počet zaměstnanců	77
Tržba na zaměstnance	108.455k
Profit margin	-921.97 %
Operating margin	-775.57 %
Gross margin	100.00 %
EBIT margin	-816.18 %
EBITDA margin	-783.82 %

EPS - Zisk na akcii	N/A
EPS - Kvartální růst	-8.00 %
EPS - Očekávaný růst příští rok	-11.11 %
Return on assets	-52.07 %
Return on equity	-69.10 %
ROIC	-49.24 %
ROCE	-53.87 %
Dluhy/Equity	0.34
Čistý dluh/EBITDA	6.72
Current ratio	9.44
Quick Ratio	9.44
Volatilita	6.09
Beta	1.14
RSI	49.49
Cílová cena analytiků	6
Známka akcie (dle analytiků)	1.40
Insider ownership	18.71 %
Institutional ownership	25.33 %
Počet akcií	99.161M
Procento shortovaných akcií	5.18 %
Short ratio	3.13 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	2010
Země	United States

Finanční výsledky akcie ABUS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	$6.011	$5.945	$10.7	$1.491	$24.873	$14.953
Cost Of Goods Sold	-	-	-	-	-	-
Gross Profit	$6.011	$5.945	$10.7	$1.491	$24.873	$14.953
Research And Development Expenses	$57.601	$57.934	$62.676	$61.253	$51.505	$38.713
SG&A Expenses	$17.727	$16.002	$16.129	$39.438	$26.438	$8.683
Other Operating Income Or Expenses	$-6.422	$-4.797	-	-	$-9.656	$-0.462
Operating Expenses	$150.085	$95.725	$121.63	$493.13	$127.195	$48.387
Operating Income	$-144.074	$-89.78	$-110.93	$-491.639	$-102.322	$-33.434
Total Non-Operating Income/Expense	$-22.305	$28.438	$2.197	$2.473	$25.016	$-5.403
Pre-Tax Income	$-166.379	$-61.342	$-108.733	$-489.166	$-77.306	$-38.837
Income Taxes	$-12.656	$-4.282	$-24.32	$-105.002	$-16.185	-
Income After Taxes	$-153.723	$-57.06	$-84.413	$-384.164	$-61.121	$-38.837
Other Income	-	-	-	-	-	-
Income From Continuous Operations	$-153.723	$-57.06	$-84.413	$-384.164	$-61.121	$-38.837
Income From Discontinued Operations	-	-	-	-	-	-
Net Income	$-164.872	$-67.151	$-85.324	$-384.164	$-61.121	$-38.837
EBITDA	$-75.739	$-72.788	$-68.105	$-99.2	$-62.726	$-32.905
EBIT	$-144.074	$-89.78	$-110.93	$-491.639	$-102.322	$-33.434
Basic Shares Outstanding	57	55	55	53	45	22
Shares Outstanding	57	55	55	53	45	22
Basic EPS	$-2.89	$-1.21	$-1.56	$-7.24	$-1.34	$-1.80
EPS - Earnings Per Share	$-2.89	$-1.21	$-1.56	$-7.24	$-1.34	$-1.80

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$90.834	$124.617	$126.352	$130.559	$181.304	$112.161
Receivables	$1.204	$1.431	$0.742	$0.566	$1.254	$1.989
Inventory	-	-	-	-	-	-
Pre-Paid Expenses	$1.79	$3.181	$2.144	$1.311	$1.196	$1.73
Other Current Assets	-	-	$0.128	$0.128	$0.128	$0.538
Total Current Assets	$93.828	$129.229	$129.366	$132.564	$183.882	$116.418
Property, Plant, And Equipment	$8.676	$10.145	$12.183	$6.945	$3.183	$1.76
Long-Term Investments	-	$22.224	$12.601	$12.601	$10.07	-
Goodwill And Intangible Assets	-	$66.307	$83.011	$123.809	$515.156	-
Other Long-Term Assets	$0.293	-	-	-	-	-
Total Long-Term Assets	$11.707	$98.676	$107.795	$143.355	$528.409	$1.76
Total Assets	$105.535	$227.905	$237.161	$275.919	$712.291	$118.178
Total Current Liabilities	$7.828	$11.239	$14.627	$10.585	$10.578	$20.206
Long Term Debt	-	-	$12.001	$12.001	-	-
Other Non-Current Liabilities	$18.992	-	-	-	-	-
Total Long Term Liabilities	$24.963	$16.432	$40.061	$62.329	$154.034	$9.937
Total Liabilities	$32.791	$27.671	$54.688	$72.914	$164.612	$30.143
Common Stock Net	$898.535	$879.405	$876.108	$867.393	$834.24	$290.004
Retained Earnings (Accumulated Deficit)	$-970.093	$-805.221	$-738.07	$-652.746	$-266.985	$-205.864
Comprehensive Income	$-48.229	$-48.17	$-48.185	$-48.185	$-49.782	$-22.313
Other Share Holders Equity	-	-	-	-	-	-
Share Holder Equity	$72.744	$200.234	$182.473	$203.005	$547.679	$88.035
Total Liabilities And Share Holders Equity	$105.535	$227.905	$237.161	$275.919	$712.291	$118.178

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$-153.723	$-57.06	$-84.413	$-384.164	$-61.121	$-38.837
Total Depreciation And Amortization - Cash Flow	$68.335	$16.992	$42.825	$392.439	$39.596	$0.529
Other Non-Cash Items	$16.607	$-23.523	$-10.199	$-65.693	$-18.629	$9.368
Total Non-Cash Items	$84.942	$-6.531	$32.626	$326.746	$20.967	$9.897
Change In Accounts Receivable	$0.227	$-1.029	$-0.129	$0.735	$0.628	$-1.887
Change In Inventories	-	-	$0.736	-	-	-
Change In Accounts Payable	-	-	-	-	-	-
Change In Assets/Liabilities	$-0.042	$-1.931	$2.587	$-1.181	$-12.582	$12.205
Total Change In Assets/Liabilities	$-2.225	$-4.275	$3.147	$-0.467	$-14.631	$16.519
Cash Flow From Operating Activities	$-71.006	$-67.866	$-48.64	$-57.885	$-54.785	$-12.421
Net Change In Property, Plant, And Equipment	$-0.578	$-1.113	$-7.261	$-3.971	$-2.287	$-0.976
Net Change In Intangible Assets	-	-	-	-	-	-
Net Acquisitions/Divestitures	-	-	-	-	$0.324	-
Net Change In Short-term Investments	$87.675	$118.566	$35.086	$-82.551	$9.645	$-41.982
Net Change In Long-Term Investments	$-58.759	$-121.58	-	$-12.601	-	-
Net Change In Investments - Total	$28.916	$-3.014	$35.086	$-95.152	$9.645	$-41.982
Investing Activities - Other	-	-	-	-	-	-
Cash Flow From Investing Activities	$28.338	$-4.127	$27.825	$-99.123	$7.682	$-42.958
Net Long-Term Debt	-	-	-	-	-	-
Net Current Debt	-	$-12.001	-	-	-	-
Debt Issuance/Retirement Net - Total	-	$-12.001	-	-	-	-
Net Common Equity Issued/Repurchased	$18.908	$1.382	$0.453	$0.637	$143.87	$60.676
Net Total Equity Issued/Repurchased	$18.908	$67.647	$49.322	$0.637	$143.87	$60.676
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	$18.549	-	-	$12.001	-	-
Cash Flow From Financial Activities	$37.457	$55.646	$49.322	$12.638	$143.87	$60.676
Net Cash Flow	$-5.143	$-17.35	$30.879	$-143.366	$94.592	$3.47
Stock-Based Compensation	$6.799	$6.241	$15.117	$39.159	$22.093	$3.283
Common Stock Dividends Paid	-	-	-	-	-	-

#	2020	2019	2018	2017	2016	2015
Current Ratio	11.9862	11.4983	8.8443	12.5238	17.3834	5.7616
Long-term Debt / Capital	-	-	0.0617	0.0558	-	-
Debt/Equity Ratio	-	-	0.0658	0.0591	-	-
Gross Margin	100	100	100	100	100	100
Operating Margin	-2396.839	-1510.177	-1036.729	-32973.77	-411.3778	-223.5939
EBIT Margin	-2396.839	-1510.177	-1036.729	-32973.77	-411.3778	-223.5939
EBITDA Margin	-1260.007	-1224.356	-636.4953	-6653.251	-252.1851	-220.0562
Pre-Tax Profit Margin	-2767.909	-1031.825	-1016.196	-32807.91	-310.8029	-259.7271
Net Profit Margin	-2742.838	-1129.537	-797.4205	-25765.52	-245.7323	-259.7271
Asset Turnover	0.057	0.0261	0.0451	0.0054	0.0349	0.1265
Inventory Turnover Ratio	-	-	-	-	-	-
Receiveable Turnover	4.9925	4.1544	14.4205	2.6343	19.8349	7.5178
Days Sales In Receivables	73.1093	87.8579	25.3112	138.558	18.4019	48.5511
ROE - Return On Equity	238.1785	-77.0061	-63.6153	-189.2386	-11.16	-44.1154
Return On Tangible Equity	-211.3205	-42.6053	-84.8696	-485.08	-187.9316	-44.1154
ROA - Return On Assets	-145.6607	-25.0368	-35.5931	-139.2307	-8.5809	-32.8631
ROI - Return On Investment	-211.3205	-28.4967	-43.4058	-178.6759	-11.16	-44.1154
Book Value Per Share	1.1229	3.6066	3.314	3.7017	10.0363	3.9235
Operating Cash Flow Per Share	-0.0166	-0.3383	0.2018	0.1145	-0.6301	-0.1347
Free Cash Flow Per Share	-0.0065	-0.2258	0.144	0.0899	-0.6353	-0.1325

Warning: Undefined array key "user" in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php on line 716

Fatal error: Uncaught mysqli_sql_exception: You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'AND valid >= CURDATE()' at line 2 in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php:11 Stack trace: #0 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php(11): mysqli_query(Object(mysqli), 'SELECT * FROM p...') #1 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php(716): Database::Execute(Object(mysqli), 'SELECT * FROM p...') #2 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(20): require_once('/data/web/virtu...') #3 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): {closure}() #4 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): Closure->__invoke() #5 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(21): Route::set('graf-akcie/ABUS', Object(Closure)) #6 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/index.php(23): require_once('/data/web/virtu...') #7 {main} thrown in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php on line 11

JenAkcie

Graf Akcie ABUS (Arbutus Biopharma Corp). Diskuze k akciím ABUS. Aktuální informace ABUS.

Základní informace o společnosti Arbutus Biopharma Corp (Akcie ABUS)

Finanční výsledky akcie ABUS